A multicenter, prospective trial to evaluate mesh-augmented sacrospinous hysteropexy for uterovaginal prolapse

• DOI: 10.1007/s00192-014-2564-x
• Publication Date: 2014-11-14T13:33:47Z
• Authors: K. Jirschele; M. Seitz; Y. Zhou; P. Rosenblatt; P. Culligan; P. Sand
• Keywords: Urogynecology; Contraindication

Hysterectomy is often part of pelvic organ prolapse repair. However, this may offer no benefit when compared to uterine preservation. We aimed prospectively evaluate a minimally invasive bilateral sacrospinous hysteropexy using polypropylene mesh. hypothesized that anatomic success and patient satisfaction can be achieved with technique.Women uterovaginal desiring surgery who had completed childbearing were enrolled. Preoperative assessment included standardized examination validated symptom pain scale questionnaires. Women prior repair or any contraindication preservation excluded. Data including demographic, operative postoperative information was collected on patients for 1 year following surgery. Continuous variables are summarized as means (standard deviation) categorical frequencies percentages. A mixed-effects model used the changes in questionnaire scores outcomes at 6 months 12 after random effects accounting center effect adjustment age.The study group comprised 99 women from three female medicine reconstructive (urogynecology) centers. The average age participants 67.0 years (11.32 years), BMI 26.04 kg/m(2) (3.56 kg/m(2)), majority multiparous (98.9%) menopausal (90.9%). Overall months, measured by composite outcome 97.7% (with Ba point landmark) 96.6% C landmark). overall exposure rate 6.52% reoperation 7.53%. All subjective improved months.Sacrospinous mesh kit an effective safe technique addressing alternative hysterectomy time